Abstract
Oral potassium permanganate has been used in the management of terminal carcinoma in three patients. Symptomatic improvement occurred in all three, with elimination of oral foetor in one patient and diminished requirement of analgesics in the other two. The mental state of each patient was improved and normal activities were resumed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Sokhi, G. The Management of Terminal Carcinoma with Oral Potassium Permanganate. Br J Cancer 24, 290–293 (1970). https://doi.org/10.1038/bjc.1970.33
Issue Date:
DOI: https://doi.org/10.1038/bjc.1970.33
This article is cited by
-
Metabolic iodine and tumours
Cellular Oncology (2017)